Cargando…
A case of methotrexate‐associated Epstein‐Barr virus‐positive mucocutaneous ulcer
Epstein‐Barr virus‐positive mucocutaneous ulcer (EBVMCU) is a B‐cell proliferative disorder that has been designated as a provisional entity in the 2017 World Health Organization classification for lymphoid neoplasms. While EBVMCU may contain varying numbers of cells with Hodgkin and Reed‐Sternberg...
Autores principales: | Sakamoto, Keiko, Baba, Takeshi, Takatori, Hiroaki, Nagao, Keisuke, Misawa, Junko, Honda, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168019/ https://www.ncbi.nlm.nih.gov/pubmed/35677919 http://dx.doi.org/10.1002/ski2.108 |
Ejemplares similares
-
Epstein-Barr Virus–Positive Mucocutaneous Ulcer in an Immunosuppressed Patient
por: Hujoel, Isabel A., et al.
Publicado: (2018) -
Multifocal Oral Epstein–Barr Virus-Positive Mucocutaneous Ulcers Associated with Dual Methotrexate and Leflunomide Therapy: A Case Report
por: Kunmongkolwut, Sumana, et al.
Publicado: (2022) -
Age-related Epstein–Barr virus-positive mucocutaneous ulcer: a case report
por: Magalhaes, Marco, et al.
Publicado: (2015) -
Epstein–Barr Virus-Positive Mucocutaneous Ulcer: A Unique and Curious Disease Entity
por: Ikeda, Tomoka, et al.
Publicado: (2021) -
Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis
por: Chan, Patrick P.Y., et al.
Publicado: (2023)